Preview: Generate Biomedicines, Inc Set To IPO Tomorrow
Benzinga Insights 8 months ago
IPOs
Generate Biomedicines, Inc (NASDAQ:GENB) IPO will take place February, 27 on the NASDAQ exchange under the ticker GENB.
The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider lock-up period of 180 days ending on August 26, 2026.
See also: Benzinga IPO Calendar
About Generate Biomedicines, Inc
Generate Biomedicines, Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.